Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxatrex Concentration in Aqueous Humor and Dry Eye Severity
NCT05213156Phase 4Completed
- Sponsor
- University General Hospital of Patras
- Start
- Sep 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ofloxacin in endophthalmitis, sponsored by University General Hospital of Patras. Primary endpoint: Dry Eye Disease severity. Started Sep 2019; status: completed.
02
Drugs
ofloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT05213156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05213156.